Nanotechnology Now - News Story: "Asklepios Bio and Bayer Healthcare Sign Research Deal"

Home > News > Asklepios Bio and Bayer Healthcare Sign Research Deal

June 3rd, 2005

Asklepios Bio and Bayer Healthcare Sign Research Deal

Abstract:
Asklepios is currently conducting preclinical testing of a synthetically designed biological nano particle (BNP) gene therapy, containing the factor IX gene for the treatment of hemophilia B.

Source:
triangletechjournal.com

Bookmark:

Related Links

Asklepios Biopharmaceutical Inc.

Bayer HealthCare

Related News Press

Investments/IPO's/Splits

Nano Labs Shareholder Update March 8th, 2014

FEI Company Announces Date for Investor Conference Participation March 3rd, 2014

Industrial Nanotech, Inc. Completes On Site Visit by PCAOB Audit Firm - Nears Completion of Audit in Preparation for Move to a Senior Stock Exchange in Late 2014 February 27th, 2014

Harris & Harris Group Announces the Consulting Engagement of Peter J. Boni as a Senior Advisor February 26th, 2014

Nanomedicine

Nano Labs Shareholder Update March 8th, 2014

MANA Research Highlight: Smart nanofibers to treat kidney failure March 6th, 2014

Harris & Harris Group, Inc. Establishes and Invests $350,001 in ProMuc, Inc. March 6th, 2014

First Look at How Individual Staphylococcus Cells Adhere to Nanostructures Could Lead to New Ways to Thwart Infections: Berkeley Lab-led research could guide the development of bacteria-resistant materials March 5th, 2014

Announcements

Nano Labs Shareholder Update March 8th, 2014

Squeezing light into metals: University of Utah engineers control conductivity with inkjet printer March 7th, 2014

Up-Converted Radio: The way to treat radio waves in a noisy environment is to turn them into visible light March 7th, 2014

Carbodeon NanoDiamonds PTFE Coating doubles surface durability and reduces friction by up to 66 percent: New surface coating enables cost-effective CO2 and fuel reductions in machinery March 6th, 2014